Beacon Angels
VC Fund
Boston, United States
Beacon Angels is a Boston-based angel group that makes investments in the $100,000 to $300,000 range in small fast-growing companies.
- Total investments:
- 34
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Beacon Angels invests in
Stages Beacon Angels invests in
Countries Beacon Angels invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Charles Fadel
|
|||
Don Burrer
|
|||
Eric Clayberg
|
|||
Leon Liebman
|
Investment Focus
Industry
- Health Care 15 (44%)
- Biotechnology 12 (35%)
- Medical 8 (24%)
- Software 7 (21%)
- Information Technology 6 (18%)
Stage
- Seed 13 (38%)
- Series A 6 (18%)
- Angel 5 (15%)
- Series B 3 (9%)
- Convertible Note 2 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Charles Fadel
Angel Investor
|
Angel Investor | Total investments: 0 | Find email | |
David A. Fogel
Member
|
Member | Total investments: 0 | Find email | |
|
Don Burrer
Member
|
Member | Total investments: 0 | Find email | |
|
Eric Clayberg
Member
|
Member | Total investments: 0 | Find email | |
|
Leon Liebman
Member
|
Member | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lenoss Medical
|
Lenoss Medical engages in providing solutions that support the natural osseous healing process. They disrupt the treatment of spinal fractures with the osteopearl VBA system, a viable, minimally invasive, and cement-free technology that utilizes the natural healing properties of healthy bone. | $6M / Convertible Note / Mar 17, 2026 | |
Gelmedix
|
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reducethe usage of drops which cause inconvenience to patients. | $13M / Seed / Feb 17, 2026 | |
Surgicure Technologies
|
Surgicure is a biotechnology start-up company that is dedicated to building effective medical instruments to prevent unnecessary harm while promoting safety and efficiency for both its patients and practitioners during surgical procedures and healing processes. Its product secures medical tubes intubated within a patient's mouth while relyingon the patient's oral cavity.Founded in 2018 by Irena Volkov, Surgicure Technologies is headquartered in Cambridge, Massachusetts. | $1.8M / Seed / Mar 12, 2025 | |
Juniper Biomedical
|
RBI Medical is a medical device company that specializes in bioelectronic medicine and selective neuromodulation treatment. The company develops a Neuromodulation system that delivers personalized stimulation to treat dysfunction and restore normal urinary retention. | $2.1M / Seed / Apr 02, 2024 | |
Jaia Robotics
|
Jaia Robotics is a provider and developer of microsized autonomous and subsurface marine vehicles. It also provides comprehensive data collection services helping clients to affordable aquatic data collection. It also provides a multi-sensor configurable technology that requires minimal user training with wide-ranging capabilities compared totraditional crewed or uncrewed data collection systems. | $1M / Seed / Jun 21, 2022 | |
Theromics
|
Theromics is the developer of a tool to address the unmet medical need to create more effective ablation zones during image-guided thermal ablation of soft tissue. Their HeatSYNC TA is used during microwave and radiofrequency ablations of cancerous tumors. Their heatSYNCTM Gel is a novel biopolymer thermal accelerant that amplifies the movement ofheat energy in soft tissue and bone. The gel is made from a naturally occurring protein and delivered via a syringe, laparoscope, or bronchoscope. | $2M / Seed / Jan 19, 2022 | |
AOA
|
AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $2.5M / Seed / Nov 15, 2021 | |
Xeno Biosciences
|
Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.It wasfounded in 2015 and is headquartered in Somerville, Massachusetts. | $7.3M / Series A / Aug 08, 2021 | |
|
AOA
|
AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $2.5M / Seed / Jun 28, 2021 | |
|
Lenoss Medical
|
Lenoss Medical engages in providing solutions that support the natural osseous healing process. They disrupt the treatment of spinal fractures with the osteopearl VBA system, a viable, minimally invasive, and cement-free technology that utilizes the natural healing properties of healthy bone. | $1.3M / Seed / Mar 25, 2021 | |
| See all 34 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Beacon Angels invest in?
Beacon Angels invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Series A stage. Most of the 34 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Beacon Angels?
Public channels for Beacon Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Beacon Angels?
The team at Beacon Angels includes Charles Fadel (Angel Investor), David A. Fogel (Member) and Don Burrer (Member), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
